NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
21/04/2026
Voltar para busca
Dado oficial do USPTO
ATOMMAP
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
20
Atualização mais recente
21/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
42
Data de depósito
19/01/2024
Data de registro
21/04/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
21/04/2026
Última transação
21/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
20/02/2023
Primeiro uso no comércio
20/02/2023
Código do desenho
4
Tipo de titular
03
Localização do titular
New York, NY, US
Examinador
MCDORMAN, ROGER THOMAS
Unidade examinadora
L90
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
A. C. (pessoa física)
A. C. (pessoa física)
Representantes
John Paul Oleksiuk COOLEY LLP
Classificação técnica
Classes Nice
Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 42
Research and development in the field of computational biologybioinformaticsgenomics; Drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceuticalmedicalscientificbiotechnologybiopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological servicesresearch and design in the field of computational chemistrymachine learning and artificial intelligence for use in chemistrybiologyphysicsbiochemistrychemical engineeringcomputer sciencedesign and optimization of moleculesmaterialsdrugs; chemistry serviceslaboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drugmolecular discovery servicesproduct development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drugmaterialsmolecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistrybiologyphysicsbiochemistrychemical engineeringcomputer sciencethe discovery of new moleculesmaterialsdrugsmachine learning techniques; computer programming in the fields of molecularmaterialsdrug development; computer consultancy services being computer software consultation in the field of drugmaterialsmolecular development; computer software consultation servicesassistance and consulting in connection with the development of computer applicationsdatabases and systems for use in the field of drugmaterialsmolecular development; consulting services in the design and implementation of computer-based information systems for businessprovision of online information relating to computer hardware and software design in the field of drugmaterialsmolecular development; creationmaintenancehostingdesign of websites in the field of drugmaterialsmolecular development; provision of online non-downloadable software for simulations for drugmaterialsmolecular discovery; provision of online non-downloadable software for use in optimizing drugmaterialsmolecular discovery; creating website based indexes of information for others using information technology for use in the field of drugmaterialsmolecular development; computer graphics design servicesrealization of computer graphics and digital imaging for use in the field of drugmaterialsmolecular development; scientific research in connection with computerized automation of technical processes for use in the field of drugmaterialsmolecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering moleculesdrugsbattery materialsother molecular products
Publicações
Histórico de despachos e eventos da marca no USPTO.
20 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
21/04/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30/03/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
30/03/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/11/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/11/2025
IUAF
USE AMENDMENT FILED
29/05/2025
EISU
TEAS STATEMENT OF USE RECEIVED
29/05/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/05/2025
EX1G
SOU EXTENSION 1 GRANTED
08/05/2025
EXT1
SOU EXTENSION 1 FILED
08/05/2025
EEXT
SOU TEAS EXTENSION RECEIVED
07/05/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
17/09/2024
PUBO
PUBLISHED FOR OPPOSITION
17/09/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/08/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
14/08/2024
DOCK
ASSIGNED TO EXAMINER
14/08/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/02/2024
NWAP
NEW APPLICATION ENTERED
24/01/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ATOMMAP ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.